GlassScriptPhysician profile
Neelu Dhingra
NPI 1437590247
$6,677.53
in general payments reported to CMS, 2019-2025
47 companies · $1,397 in 2025
The $1,397 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $648 · 2020: $263 · 2021: $782 · 2022: $501 · 2023: $1,522 · 2024: $1,565 · 2025: $1,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,433 · Education: $50.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,433.38 |
| Education | $50.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,227.09 | 2019-2025 | |
| Abbvie INC. | $936.65 | 2021-2025 | Duopa, Qulipta, Ubrelvy |
| Ucb, INC. | $826.15 | 2020-2025 | Fintepla, Briviact, Nayzilam |
| Acadia Pharmaceuticals INC | $394.79 | 2022-2025 | Nuplazid, Daybue |
| Sk Life Science, INC. | $302.89 | 2021-2025 | |
| Catalyst Pharmaceuticals, INC. | $263.04 | 2023-2025 | Fycompa |
| Lilly USA, LLC | $213.67 | 2019-2024 | Emgality, Reyvow |
| Biogen, INC. | $174.06 | 2019-2025 | Skyclarys |
| Alexion Pharmaceuticals, INC. | $162.63 | 2019-2025 | Ultomiris |
| Amgen INC. | $161.18 | 2019-2025 | Uplizna |
| Pfizer INC. | $154.39 | 2023-2025 | |
| Neurelis, INC. | $152.71 | 2023-2025 | Valtoco |
| Jazz Pharmaceuticals INC. | $148.92 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $145.52 | 2021-2025 | Austedo Xr, Austedo Xr |
| Supernus Pharmaceuticals, INC. | $122.80 | 2019-2020 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neelu Dhingra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.